Olstein Capital Management’s Zimmer Biomet ZBH Stock Holding History

Olstein Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-87,000	Closed	-$7.87M	–	96
2026 Q1	$7.87M	Buy	87,000 +5,000	+6%	+$459K	1.72%	11
2025 Q4	$7.37M	Buy	82,000 +4,000	+5%	+$379K	1.51%	17
2025 Q3	$7.68M	Hold	78,000	–	–	1.45%	17
2025 Q2	$7.11M	Sell	78,000 -2,000	-3%	-$193K	1.33%	30
2025 Q1	$9.05M	Hold	80,000	–	–	1.67%	12
2024 Q4	$8.45M	Hold	80,000	–	–	1.49%	18
2024 Q3	$8.64M	Buy	80,000 +2,600	+3%	+$284K	1.47%	22
2024 Q2	$8.4M	Buy	77,400 +12,400	+19%	+$1.46M	1.49%	19
2024 Q1	$8.58M	Sell	65,000 -1,635	-2%	-$204K	1.4%	25
2023 Q4	$8.11M	Buy	66,635 +9,635	+17%	+$1.08M	1.37%	29
2023 Q3	$6.4M	Buy	57,000 +10,000	+21%	+$1.27M	1.1%	51
2023 Q2	$6.84M	Sell	47,000 -8,000	-15%	-$1.09M	1.11%	46
2023 Q1	$7.11M	Sell	55,000 -2,000	-4%	-$251K	1.11%	46
2022 Q4	$7.27M	Sell	57,000 -31,500	-36%	-$3.66M	1.14%	44
2022 Q3	$9.25M	Sell	88,500 -96,500	-52%	-$10.6M	1.55%	10
2022 Q2	$21.7M	Buy	185,000 +85,000	+85%	+$10.1M	3.25%	2
2022 Q1	$12.8M	Sell	100,000 -34,518	-26%	-$4.16M	1.6%	7
2021 Q4	$16.6M	Buy	134,518 +31,518	+31%	+$4.12M	1.98%	4
2021 Q3	$14.6M	Buy	103,000 +33,990	+49%	+$5M	1.79%	6
2021 Q2	$10.8M	Sell	69,010 -4,120	-6%	-$667K	1.36%	21
2021 Q1	$11.4M	Hold	73,130	–	–	1.59%	13
2020 Q4	$10.9M	Sell	73,130 -2,215	-3%	-$313K	1.75%	13
2020 Q3	$9.96M	Sell	75,345 -7,055	-9%	-$922K	1.81%	6
2020 Q2	$9.55M	Sell	82,400 -4,429	-5%	-$510K	1.78%	7
2020 Q1	$8.52M	Buy	86,829 +5,459	+7%	+$716K	1.87%	6
2019 Q4	$11.8M	Sell	81,370 -1,442	-2%	-$199K	1.83%	2
2019 Q3	$11M	Sell	82,812 -27,398	-25%	-$3.54M	1.73%	5
2019 Q2	$12.6M	Buy	110,210 +7,210	+7%	+$844K	2.04%	2
2019 Q1	$12.8M	Sell	103,000 -7,056	-6%	-$802K	2.11%	1
2018 Q4	$11.1M	Buy	110,056 +361	+0.3%	+$40.6K	1.81%	4
2018 Q3	$14M	Sell	109,695 -35,937	-25%	-$4.27M	1.87%	2
2018 Q2	$15.8M	Buy	145,632 +3,966	+3%	+$432K	2.09%	3
2018 Q1	$15M	Sell	141,666 -4,810	-3%	-$559K	1.91%	4
2017 Q4	$17.2M	Buy	146,476 +9,795	+7%	+$1.11M	2.19%	4
2017 Q3	$15.5M	Buy	136,681 +22,598	+20%	+$2.61M	2%	5
2017 Q2	$14.2M	Sell	114,083 -26,661	-19%	-$3.16M	1.81%	8
2017 Q1	$16.7M	Sell	140,744 -36,236	-20%	-$4.11M	2.14%	2
2016 Q4	$17.7M	Buy	176,980 +109,000	+160%	+$11.7M	2.29%	1
2016 Q3	$8.58M	Sell	67,980 -10,300	-13%	-$1.27M	1.13%	33
2016 Q2	$9.15M	Sell	78,280 -30,900	-28%	-$3.5M	1.24%	26
2016 Q1	$11.3M	Sell	109,180 -11,330	-9%	-$1.1M	1.51%	18
2015 Q4	$12M	Buy	120,510 +6,180	+5%	+$605K	1.55%	14
2015 Q3	$10.4M	Buy	114,330 +38,110	+50%	+$3.82M	1.3%	22
2015 Q2	$8.08M	Buy	76,220 +3,090	+4%	+$342K	0.84%	51
2015 Q1	$8.34M	Sell	73,130 -11,330	-13%	-$1.29M	0.9%	50
2014 Q4	$9.3M	Sell	84,460 -26,780	-24%	-$2.82M	1.14%	31
2014 Q3	$10.9M	Buy	111,240 +21,630	+24%	+$2.13M	1.41%	9
2014 Q2	$9.04M	Buy	89,610 +20,600	+30%	+$2.01M	1.22%	24
2014 Q1	$6.34M	Sell	69,010 -4,120	-6%	-$380K	0.87%	57
2013 Q4	$6.62M	Sell	73,130 -5,150	-7%	-$446K	0.95%	48
2013 Q3	$6.24M	Sell	78,280 -15,450	-16%	-$1.22M	0.96%	46
2013 Q2	$6.82M	Buy	+93,730	New	+$7.01M	1.09%	37

Other funds holding ZBH

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

CapitalatWork SA Auderghem $3.99B AUM

MPMG

Minneapolis Portfolio Management Group Wayzata, Minnesota $1.06B AUM 63.37% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Olstein Capital Management's ZBH Position: Q2 2026 in Review

Olstein Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 87,000 shares — an estimated $7.87M sold.

Olstein Capital Management first reported a position in ZBH in Q2 2013 and held it in 52 quarters. The position peaked at $21.7M in Q2 2022. 348 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Olstein Capital Management reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Olstein Capital Management sold 87,000 Zimmer Biomet shares in Q2 2026, an estimated $7.87M.
Olstein Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 52 quarters.
Olstein Capital Management's Zimmer Biomet position peaked at $21.7M in Q2 2022.
348 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Olstein Capital Management's 13F filing for Q2 2026.